Greenleaf Trust Increases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Greenleaf Trust increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,522 shares of the company’s stock after buying an additional 611 shares during the quarter. Greenleaf Trust’s holdings in GE HealthCare Technologies were worth $504,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Chicago Capital LLC boosted its holdings in GE HealthCare Technologies by 2.8% during the third quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after buying an additional 163 shares in the last quarter. Chilton Capital Management LLC boosted its holdings in GE HealthCare Technologies by 15.4% during the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after buying an additional 164 shares in the last quarter. Procyon Advisors LLC boosted its holdings in GE HealthCare Technologies by 5.2% during the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after buying an additional 175 shares in the last quarter. Meeder Advisory Services Inc. boosted its holdings in GE HealthCare Technologies by 5.4% during the fourth quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock worth $281,000 after buying an additional 185 shares in the last quarter. Finally, Forum Financial Management LP boosted its holdings in GE HealthCare Technologies by 3.9% during the third quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock worth $339,000 after buying an additional 186 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on GEHC. Argus increased their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Evercore ISI upped their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. HSBC began coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective for the company. Mizuho upped their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Finally, UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $95.09.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $84.31 on Tuesday. The firm has a 50-day simple moving average of $88.76 and a 200-day simple moving average of $78.08. The stock has a market capitalization of $38.47 billion, a price-to-earnings ratio of 27.92, a price-to-earnings-growth ratio of 2.94 and a beta of 0.95. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period last year, the business earned $1.31 earnings per share. GE HealthCare Technologies’s revenue was up 5.3% compared to the same quarter last year. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is currently 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.